Gene: SULT1B1
Official Full Name: sulfotransferase family 1B member 1provided by HGNC
Gene Summary: Sulfotransferase enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs, and xenobiotic compounds. These cytosolic enzymes are different in their tissue distributions and substrate specificities. The gene structure (number and length of exons) is similar among family members. However, the total genomic length of this gene is greater than that of other SULT1 genes. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27691 | SULT1B1 Knockout cell line (HEK293) | Human | SULT1B1 | 1:3~1:6 | Negative | Online Inquiry |
SULT1B1 Gene Knockout Cell Lines are genetically engineered cell lines designed to lack the SULT1B1 gene, which encodes for the sulfotransferase enzyme involved in drug metabolism and the detoxification of various steroid and xenobiotic compounds. By employing advanced CRISPR-Cas9 technology for precise gene editing, these knockout cell lines facilitate a deeper investigation into the role of SULT1B1 in cellular functions, drug interactions, and various metabolic pathways.
The primary mechanism of action of these cell lines involves the complete absence of the SULT1B1 enzyme, which allows researchers to delineate the enzyme's contributions and observe resultant physiological changes. This functionality is vital for understanding how genetic variations affect drug metabolism, leading to implications in both personalized medicine and toxicity assessments. These cell lines are indispensable tools in pharmacology, toxicology, and biochemical research, providing a platform for studying drug efficacy and adverse reactions without the confounding effects of the SULT1B1 enzyme.
In comparison to other gene-editing tools or traditional cell lines, SULT1B1 Gene Knockout Cell Lines offer a unique advantage by enabling specific manipulation of the metabolic pathways with minimal off-target effects. This precision enhances experimental accuracy and empowers researchers to derive conclusive insights faster and more reliably. Additionally, these cell lines come with excellent reproducibility, making them ideal for high-throughput screening applications.
For researchers and clinicians alike, utilizing SULT1B1 Gene Knockout Cell Lines translates into substantial benefits such as reduced discovery times for new therapeutics and improved safety profiles for drugs undergoing development. By offering a specific focus on the SULT1B1 enzymatic pathway, these cell lines provide unparalleled insights into metabolic processes that can significantly influence clinical outcomes.
Our company specializes in providing high-quality biological products and innovative solutions for research. With a commitment to advancing scientific understanding, we support the research community by delivering products that meet rigorous standards of accuracy and reliability.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.